ELIZABETH WILSON: Open Payments
NPI 1013294198 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 20 payments from 18 companies in 2025. Trend: 2023 $384 · 2024 $492 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| ABBVIE INC. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Celgene Corporation | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $28 |
| BeOne Medicines USA, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| Genmab U.S., Inc. | 1 | $23 |
Products named: RYBREVANT, FRUZAQLA, ELAHERE, Fabhalta, REBLOZYL, Zoladex, CALQUENCE, BRUKINSA.
Industry payments across DE — which companies pay providers there.
